The SARS-CoV-2 Spike variant D614G favors an open conformational state
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Symmetrization of contacts in D614G SARS-CoV-2 Spike favors greater probability of infection-capable conformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7 RBD is more exposed in the one-up conformation. (A) Surface representation of the all-down Spike complex. Colors ranging between red, white, and blue represent values for the GEF. GEF describes relative exposure and coverage of protein surfaces. (B) Surface representation of the one-up Spike. Colors ranging between cyan, white, and magenta indicate GEF differences between the closed and open structures. The RBD in the up orientation is indicated by the dotted circle, where the originally buried (magenta) region around 458 to 478 is now exposed. (C and D) Top view of the Spike protein apex in (C) all-down and (D) one-up conformations. Protein surface is shown in gray. Glycan ensembles covering the protein surface are represented by point densities. Fucosylated 2 and 3 antennae complex (FA2 and FA3) glycans and oligomannose (OM) glycans are depicted in dark red, orange, and green. Binding site region, which includes RBM (residues 438 to 506) and C105 antibody binding residues (i.e., 403, 405, 406, 408, 409, 415 to 417, 420, 421, 449, 453, 455 to 460, 473 to 477, 486, 487, 489, 493 to 496, 498, and 500 to 505), is colored yellow. These binding site residues are more exposed in the one-up conformation, compared to the all-down case. (E) Representative configuration describing S309 Fab binding to an up-RBD in G-form that shows no rotation toward NTD of the neighboring protomer on the right (~0° rolling angle) (top view of the Spike is shown). This structure shows that the Fab domain does not sterically clash with the Spike protein. (F) Representative configuration showing S309 Fab binding to an up-RBD in D-form where the RBD is rotated toward the NTD of the neighboring protomer on the right [rolling angle is <−10°; same view as in (E) is shown]. The Fab domain starts to sterically clash with the Spike protein NTD of the neighboring protomer. See Supplementary Materials and Methods and fig. S7 for details on RBD rotations.](https://figures.cochat.ai/paper-figures/aa66899fbf54404c86024638352dc87b/the-sars-cov-2-spike-variant-d614g-favors-an-open-conformational-state-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the G614 form, due to the relaxation of tensile hydrogen bonds, a higher population of infection capable of open configurations results in higher chances of binding events with the host receptor ACE-2, thereby increasing the overall infectivity.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is well established that mutation D614G increases viral transmission and promotes ACE2 engagement”
From The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2022) · cites this paper as Mansbach et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“in the G614 form, due to the relaxation of tensile hydrogen bonds, a higher population of infection capable of open configurations results in higher chances of binding events with the host receptor ACE-2, thereby increasing the overall infectivity.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Structural analysis by atomic simulations and molecular-level studies showed asymmetric inter-promoter interactions between S1 and S2 subunits in the open state during the D614 form.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Enhanced exposure of RBD in the open configuration is also predicted to be a reason for higher sensitivity toward neutralization [27].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952 · cited 4×
“W. Humphrey, A. Dalke, K. Schulten, VMD: Visual molecular dynamics.”
InfluentialUCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298 · cited 1×
“3 software packages (30, 31), using the CHARMM36m (32) force field and TIP3P water model (33).”
Matplotlib: a 2D graphics environment
Hunter, J. D. (2007) · Computing in Science & Engineering · doi:10.1109/mcse.2007.55 · Cited by 39,249 · cited 1×
“A careful analysis 66 of RBD exposure, including the role of the highly-flexible glycans, showed that both the ACE2 67 binding site and critical neutralizing antibody epitopes in the RBD are more accessible in the one68 up state (1), (7), (8).”
Molecular dynamics with coupling to an external bath
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984) · The Journal of Chemical Physics · doi:10.1063/1.448118 · Cited by 30,700
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190 · cited 1×
“3 software packages (30, 31), using the CHARMM36m (32) force field and TIP3P water model (33).”
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 9×
“model based on DOPE and Procheck scores (5), (6).”
InfluentialA smooth particle mesh Ewald method
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 22,514 · cited 1×
“12 nm, an interpolation order of 4, and a tolerance of 1 × 10−5 (37).”
GROMACS: Fast, flexible, and free
Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20291 · Cited by 19,182
LINCS: A linear constraint solver for molecular simulations
Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h · Cited by 18,260
Research works printed but not linked: 1
- 10.1021/bi962514 · doi:10.1021/bi962514
Cited by
Items 101–200 of 202
Jahangir, M. A. (2021) · International Journal of Pharmaceutics & Pharmacology · doi:10.31531/2581-3080.1000153 · Cited by 13
Manrique, P. D., Chakraborty, S., Henderson, R. C., Edwards, R. J., Mansbach, R. A., Nguyen, K., Stalls, V., Saunders, C., Mansouri, K., Acharya, P., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105855 · Cited by 15
Self-citationVerkhivker, G. M., Agajanian, S., Öztaş, D. Y., & Gupta, G. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1933594 · Cited by 13
Hadi‐Alijanvand, H., Paola, L. D., Hu, G., Leitner, D. M., Verkhivker, G. M., Sun, P., Poudel, H., & Giuliani, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c00154 · Cited by 12
Kwarteng, A., Asiedu, E., Sylverken, A. A., Larbi, A. A., Sakyi, S. A., & Asiedu, S. O. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104815 · Cited by 13
Pacheco-Olvera, D. L., Remy-Hernández, S. S., García-Valeriano, M. G., Rivera-Hernández, T., & López-Macías, C. I. R. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.10.007 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 13
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · Biomolecules · doi:10.3390/biom12070964 · Cited by 11
Rego, N., Salazar, C., Paz, M., Costábile, A., Fajardo, Á., Ferrés, I., Perbolianachis, P., Fernández-Calero, T., Noya, V., Machado, M. R., et al. (2021) · Viruses · doi:10.3390/v13091801 · Cited by 11
Verkhivker, G. M., Agajanian, S., Öztaş, D. Y., & Gupta, G. (2021) · ACS Omega · doi:10.1021/acsomega.1c02336 · Cited by 11
The basis of mink susceptibility to SARS-CoV-2 infection
Barua, A., Grot, N., & Pławski, A. (2022) · Journal of Applied Genetics · doi:10.1007/s13353-022-00689-w · Cited by 10
Veneziano, C., Marascio, N., Marco, C. D., Quaresima, B., Biamonte, F., Trecarichi, E. M., Santamaria, G., Quirino, A., Torella, D., Quattrone, A., et al. (2023) · Viruses · doi:10.3390/v15020408 · Cited by 13
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2
Ma, Y., Li, P., Hu, Y., Qiu, T., Wang, L., Lu, H., Lv, K., Xu, M., Zhuang, J., Liu, X., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011123 · Cited by 11
Tu, Y., & Meng, X. (2023) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2023.06.023 · Cited by 10
Application of Bulky NHC–Rhodium Complexes in Efficient S–Si and S–S Bond Forming Reactions
Bołt, M., & Żak, P. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c02160 · Cited by 10
Mehra, R., & Kepp, K. P. (2022) · European Biophysics Journal · doi:10.1007/s00249-022-01619-8 · Cited by 10
Sars-escape network for escape prediction of SARS-COV-2
Bist, P. S., Tayara, H., & Chong, K. T. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad140 · Cited by 9
Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation
Al-Jaf, S. M. A., Niranji, S. S., & Mahmood, Z. H. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100950 · Cited by 9
Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike
Li, Y., Zheng, P., Liu, T., Shi, C., Wang, B., Xu, Y., & Jin, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.930931 · Cited by 12
Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines
Maison, D. P., Ching, L. L., Cleveland, S. B., Tseng, A. C., Nakano, E. T., Shikuma, C. M., & Nerurkar, V. R. (2022) · Communications Biology · doi:10.1038/s42003-022-04030-3 · Cited by 10
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Valenzuela-Fernández, A., Cabrera-Rodríguez, R., Ciuffreda, L., Pérez-Yanes, S., Estévez‐Herrera, J., González‐Montelongo, R., Alcoba-Flórez, J., Trujillo‐González, R., de Artola, D. G.-M., Gil-Campesino, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1052436 · Cited by 10
de Souza, A. S., Amorim, V. M. D. F., de Souza, R. F., & Guzzo, C. R. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2142296 · Cited by 9
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development
Huan, X., Zhan, J., & Gao, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1407149 · Cited by 8
Verkhivker, G. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042172 · Cited by 10
Yan, Z., Li, X., Ma, Y., & Ding, H. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c02316 · Cited by 8
Geromichalou, E. G., & Geromichalos, G. D. (2022) · Molecules · doi:10.3390/molecules27217572 · Cited by 10
Alshahrani, M., Parikh, V., Foley, B., & Verkhivker, G. M. (2025) · Viruses · doi:10.3390/v17060741 · Cited by 8
Teruel, N., Crown, M. R., Rajsbaum, R., Bashton, M., & Najmanovich, R. (2025) · Virus Evolution · doi:10.1093/ve/veaf027 · Cited by 7
Cancer treatment in the coronavirus disease pandemic
Zhang, J., Zhong, W., & Wu, Y.-L. L. C. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.12.012 · Cited by 8
Boon, S. S., Xia, C., Wang, M. H., Yip, K. L., Luk, H. Y., Li, S., Ng, R. W. Y., Lai, C. K. C., Chan, P. K. S., & Chen, Z. (2021) · mBio · doi:10.1128/mbio.02687-21 · Cited by 9
In-Silico study of antivirals and non-antivirals for the treatment of SARS-COV-2
dos Santos, A. F., Martins, M. O., Montagner, G. E., Schultz, J. V., Gomes, P., Zanella, I., & Fagan, S. B. (2022) · Disciplinarum Scientia | Naturais e Tecnológicas · doi:10.37779/nt.v23i2.4200 · Cited by 8
Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates
Prathiviraj, R., Chellapandi, P., Begum, A., Kiran, G. S., & Selvin, J. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198618 · Cited by 7
Kim, D. G., Kim, H. S., Choi, Y., & Stan, R. C. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.045 · Cited by 7
“Dissociation between the Spike monomers has two key roles for viral infectivity: to expose the fusion molecular machinery required for cell entry [7] and to promote RBD opening necessary for binding to cell entry receptor ACE2 [8].”
Barrett, C. T., Neal, H. E., Edmonds, K. L., Moncman, C. L., Thompson, R., Branttie, J. M., Boggs, K. B., Wu, C., Leung, D. W., & Dutch, R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.24.428007 · Cited by 8
de Souza, A. S., de Souza, R. F., & Guzzo, C. R. (2023) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-023-00534-0 · Cited by 7
Lina, B. (2021) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2021.11.002 · Cited by 6
Paulino-Ramírez, R., López, P. L., Mueses, S., Cuevas, P., Jabier, M., & Rivera‐Amill, V. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20085503 · Cited by 7
Variation in structural motifs within SARS-related coronavirus spike proteins
Hills, F. R., Eruera, A.-R., Hodgkinson‐Bean, J., Jorge, F., Easingwood, R. A., Brown, S. H. J., Bouwer, J. C., Li, Y., Burga, L. N., & Bostina, M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012158 · Cited by 6
Synthetic proteins for COVID-19 diagnostics
Schein, C. H., Levine, C. B., McLellan, S., Negi, S. S., Braun, W. A., Dreskin, S. C., Anaya, E. S., & Schmidt, J. G. (2021) · Peptides · doi:10.1016/j.peptides.2021.170583 · Cited by 6
Stromberg, Z. R., Theiler, J. P., Foley, B. T., y Gutiérrez, A. M., Hollander, A., Courtney, S. J., Gans, J. D., Deshpande, A., Martinez‐Finley, E. J., Mitchell, J., et al. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000207 · Cited by 6
Zhang, L., Cui, Z., Li, Q., Yu, Y., Wu, J., Nie, J., Ding, R., Wang, H., Zhang, Y., Liu, S., et al. (2021) · doi:10.21203/rs.3.rs-492659/v1 · Cited by 5
Factors for COVID-19 Infection that Govern the Severity of Illness
Ghosh, B., Sarkar, S., Sepay, N., Das, K., Das, S., & Dastidar, S. G. (2021) · SciMedicine Journal · doi:10.28991/scimedj-2021-0302-9 · Cited by 6
Verkhivker, G. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031646 · Cited by 6
Giorgi, E. E., Tanmoy Bhattacharya, A., Fischer, W., Yoon, H., Abfalterer, W., & Korber, B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.29.428535 · Cited by 5
Self-citationBoukadida, C., Taboada, B., Escalera‐Zamudio, M., Iša, P., Ramírez–González, J. E., Vázquez-Pérez, J. A., Muñoz‐Medina, J. E., Grajales-Muñíz, C., González-Torres, C., Gaytán-Cervantes, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01249-21 · Cited by 4
Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins
Kumar, S., Dasgupta, S., Sajadi, M. M., Snyder, G. A., DeVico, A. L., & Ray, K. (2024) · Viruses · doi:10.3390/v16030407 · Cited by 4
Lebanese SARS-CoV-2 genomics: 24 months of the pandemic
Fayad, N., Habib, W. A., El‐Shesheny, R., Kandeil, A., Mourad, Y., Mokhbat, J., Kayali, G., Goldstein, J., & Abdallah, J. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198824 · Cited by 4
Mani, N., Suresh, R., & Chakraborty, S. (2025) · Protein Science · doi:10.1002/pro.70368 · Cited by 3
Self-citationLopes-Ribeiro, Á., Oliveira, P. D. M., Retes, H. M., Barbosa‐Stancioli, E. F., da Fonseca, F. G., Tsuji, M., & Coelho-dos-Reis, J. G. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229712 · Cited by 4
MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
Lee, S., Jang, S., Kang, J., Park, S. B., Han, Y. W., Nam, H., Kim, M., Lee, J., Cho, K. J., Kim, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778829 · Cited by 3
Jain, M., Patil, N., Gor, D., Sharma, M. K., Goel, N., & Kaushik, P. (2022) · Proteomes · doi:10.3390/proteomes10040034 · Cited by 3
Variation Analysis of SARS-CoV-2 Complete Sequences from Iran
Moradi, J., Moradi, P., Alvandi, A., Abiri, R., & Moghoofei, M. (2022) · Future Virology · doi:10.2217/fvl-2021-0056 · Cited by 3
The SARS-CoV-2 spike protein structure: a symmetry tale on distortion trail
Tuvi‐Arad, I., & Shalit, Y. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp00163f · Cited by 3
Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
Dormeshkin, D., Katsin, M., Stegantseva, M. V., Golenchenko, S., Shapira, M. A., Dubovik, S., Lutskovich, D. V., Kavaleuski, A., & Meleshko, A. (2023) · Vaccines · doi:10.3390/vaccines11061014 · Cited by 3
Petrea, C. L., Ciortea, D.-A., Gurău, G., Matei, M. N., Pleșea-Condratovici, A., Zaharia, A. E., (Ivașcu), C. B., Verga, G. I., & Berbece, S. I. (2026) · Biomedicines · doi:10.3390/biomedicines14020258 · Cited by 2
Is Gain of Function a Reliable Tool for Establishing Sars-Cov-2 Origin?
Guardo, G. D. (2022) · Advances in Microbiology · doi:10.4236/aim.2022.123009 · Cited by 2
Lv, N., & Cao, Z. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp03425e · Cited by 2
Alpha to Omicron (Variants of Concern): Mutation Journey, Vaccines, and Therapy
Hamad, M., AlKhamach, D. M. H., Alsayadi, L. M., Sarhan, S. A., Saeed, B. Q., Sokóvić, M., Hadda, T. B., & Soliman, S. S. M. (2023) · Viral Immunology · doi:10.1089/vim.2022.0122 · Cited by 2
Prathiviraj, R., Prinsha, K., Hassan, S., Kumar, S., Kiran, G. S., & Selvin, J. (2023) · Medicine in Omics · doi:10.1016/j.meomic.2023.100024 · Cited by 2
Application of Omics and Bioinformatics Technologies in Response to COVID-19 Pandemic
Aga, A. M., & Woldesemayat, A. A. (2024) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v8i1.363 · Cited by 2
Alshahrani, M., Parikh, V., Foley, B., Raisinghani, N., & Verkhivker, G. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041507 · Cited by 3
Silva, Y. F. E., Fokoue, H. H., & Batista, P. R. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00990 · Cited by 3
Ye, H., Wang, H., Zhao, F., Tang, J., Wang, Y., Yu, H., & Xiao, S. (2025) · Journal of Transport & Health · doi:10.1016/j.jth.2025.102014 · Cited by 1
Genetic diversity analysis of the SARS-CoV-2 virus: a literature review
Colac, S., Ulinici, M., & Burduniuc, O. (2025) · One Health & Risk Management · doi:10.38045/ohrm.2025.1.02 · Cited by 1
Evolutionary aspect of spike glycoprotein's conformational dynamics
Xu, W., Guo, T., & Su, H. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp04391c · Cited by 1
Schulz, F., Dreisler, M. W., Koylyu, D., Valero, J., Malle, M. G., Civit, L., Kjems, J., & Hatzakis, N. S. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00883 · Cited by 1
Beeckmans, S., & DRIESSCHE, E. V. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671923 · Cited by 2
“Other studies, on the contrary, suggest that the D 614 G mutant rather loosens the spike protein and brings its subunits more easily in the open state, which should facilitate the binding to its ACE2 receptor (Mansbach et al., 2020).”
BackgroundSARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
Rocha, W. S., Zhan, P., & da Silva‐Júnior, E. F. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230411095417 · Cited by 2
Human SARS CoV-2 spike protein mutations in West Africa
(2023) · Health Sciences Investigations Journal · doi:10.46829/hsijournal.2023.6.4.1.443-447 · Cited by 1
Current Progress in Genomic and Genetic Research on Human Viral Diseases
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4833-2 · Cited by 1
Zahmatkesh, A., Salmasi, E., & Gholizadeh, R. (2024) · Bioimpacts · doi:10.34172/bi.2024.30150 · Cited by 1
Mao, B., Le‐Trilling, V. T. K., Tang, H., Hu, J., Schmitz, M., Barbet, K., Xu, D., Wei, Z., Guo, B., Mennerich, D., et al. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199485 · Cited by 1
Li, Q., Cai, X., Li, X., Zhang, Y.-B., Li, R., Kang, Z., Wan, D., Wang, J., Li, L., Yang, J., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01007-25 · Cited by 2
Shah, M., Moon, S. U., & Woo, H. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.30.424801 · Cited by 3
Simple Formulae, Deep Learning and Elaborate Modelling for the COVID-19 Pandemic
FOKAS, A. S., Δικαίος, Ν., Tsiodras, S., & Kastis, G. A. (2022) · Encyclopedia · doi:10.3390/encyclopedia2020047 · Cited by 1
Dutta, M., & Voth, G. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563184 · Cited by 1
Guo, C., Sachithanandham, J., Zhong, W., Craney, M. C., Villano, J., Pekosz, A. S., & Gould, S. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.04.574272 · Cited by 1
pH-induced structural changes in SARS-CoV-2 spike variantsPreprint
Oliveira, A. S. F., Tulli, L., Kearns, F. L., Casalino, L., Rosenfeld, M. A., Berger, I., Schaffitzel, C., Davidson, A. D., Haddrell, A. E., Reid, J. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.17.688702 · Cited by 1
Kwarteng, A., Asiedu, E., Sylverken, A. A., Larbi, A. A., & Twumasi, P. (2021) · Research Square · doi:10.21203/rs.3.rs-98463/v2
Network analysis outlines strengths and weaknesses of emerging SARS-CoV-2 Spike variantsPreprint
Manrique, P. D., Chakraborty, S., Nguyen, K., Mansbach, R. A., Korber, B., & Gnanakaran, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.03.458946
Self-citationIdentification of Genotypic Variants and its Proteomic mutations of Brazilian SARS-CoV-2 IsolatesPreprint
Prathiviraj, R., Chellapandi, P., Kiran, G. S., & Selvin, J. (2021) · doi:10.22541/au.162578181.18050136/v1
COVID-19 or SARS-COV-2 Works Published and Presentations 2020-2021
Fitch, J. P. (2021) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/1835750
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.11.487920
Kwarteng, A., Asiedu, E., Sylverken, A. A., Larbi, A. A., & Twumasi, P. (2021) · Research Square · doi:10.21203/rs.3.rs-98463/v3
Fuentes-Acosta, M., Mulia-Rodríguez, J., & Osorio-González, D. (2023) · Creative Education · doi:10.4236/ce.2023.141008
Shi, C., Jiao, Y., Yang, C., & Sun, Y. (2023) · RSC Advances · doi:10.1039/d3ra00198a
Spike (S) Glycoprotein D614G Mutant
Zhang, J. (2023) · Springer series in biophysics · doi:10.1007/978-3-031-36773-1_8
Tracking SARS-CoV-2 variants in Kurdistan Region of Iraq.
Mohamedsalih, P. M., Salih, K. J., Kareem, B. O., & Sabir, D. K. (2023) · ZANCO Journal of Pure and Applied Sciences · doi:10.21271/zjpas.35.5.12 · Cited by 1
Immunological storm and multiple organ damage by COVID-19
Arafath, A. Y., Fathima, S. A., Prabhakaran, A., Hassan, S., Prathiviraj, R., Kiran, G. S., & Selvin, J. (2024) · Medicine in Omics · doi:10.1016/j.meomic.2024.100034
Molecular recognition of anion binding proteins: Characterization and inhibition
Schuurs, Z. P. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.246091
Gellenoncourt, S. (2022) · theses.fr (ABES) · doi:10.70675/fa2f63dczb338z4139zbcb7ze0f19f5f9862
Dautović, D. O., Džuho, A., & Ašić, A. (2024) · Genetics & Applications · doi:10.31383/ga.vol8iss1ga03
The structure-based approaches to computing viral fitness
Mehra, R., & Thakur, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.004 · Cited by 1
Tracking the opening of spike crowns on the surface of coronavirusesPreprint
Wu, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.02.686173
Kwarteng, A., Asiedu, E., & Sylverken, A. A. (2020) · Research Square · doi:10.21203/rs.3.rs-98463/v1
Brazil, C. L. (2022) · Kent Academic Repository (University of Kent) · doi:10.22024/unikent/01.02.99218
Gonzales-Flores, K., Castañeda-Priego, R., & Alarcón, F. (2026) · arXiv (Cornell University) · doi:10.48550/arxiv.2602.09301
Usama, M., Azeem, M., & Mustafa, G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0346242
Caractérisation de la diversité génétique de SARS-CoV-2 dans des échantillons cliniques
Bader, W. (2022) · theses.fr (ABES) · doi:10.70675/09aee16fz8ab8z4823za3d0z6866bfbc0a6c
Nouveaux agents supramoléculaires anti-adhésifs contre SARS-cov-2
Boulo, L. (2024) · theses.fr (ABES) · doi:10.70675/540d01e6z0766z4fd5z804ezedabf2c230e9
Metadata
- Authors
- Mansbach, R. A., Chakraborty, S., Nguyen, K., Montefiori, D. C., Korber, B., & Gnanakaran, S.
- Affiliations
- Los Alamos National Laboratory (US)
- Duke University (US)
- Corresponding author
- Gnanakaran, S.
- ORCID
- Venue
- Science Advances
- Published
- 2021-04-16
- Volume
- 7
- Issue
- 16
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8051874
- OpenAlex
- W3153528761
- Cited by
- 206
- References
- 59
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 26 · 2022: 64 · 2021: 68
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- U.S. Department of Energy (89233218CNA000001)
- NIH Office of the Director (P50GM085273)
- Los Alamos National Laboratory (Director’s Postdoctoral Fellowship, Center of Nonlinear Studies Postdoctoral Program, 20200706ER)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- SARS-CoV-2, spike protein, D614G mutation, protein conformational dynamics, receptor binding domain, ACE2 binding, viral infectivity, neutralizing antibodies, vaccine design, COVID-19 pandemic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.